Trisomy 6 is a chromosomal condition in which cells carry three copies of chromosome 6 instead of the usual two. In its complete form, where every cell in the body has the extra chromosome, it is almost universally lethal and typically ends in miscarriage during the first trimester. Mosaic trisomy 6, in which only some cells carry the extra copy, is extraordinarily rare in liveborns but represents the only version compatible with survival. The condition sits at an unusual intersection of prenatal genetics because even when the fetus itself is chromosomally normal, leftover traces of trisomy 6 in the placenta or a related phenomenon called uniparental disomy can still cause health problems worth understanding.
Why Complete Trisomy 6 Is Almost Always Fatal
Chromosome 6 is a large chromosome packed with genes critical to immune function, cell signaling, and early embryonic development. When every cell in a developing embryo carries three copies, the resulting gene-dosage imbalance is severe enough that the pregnancy cannot progress. Most pregnancies with complete trisomy 6 end in spontaneous miscarriage, often so early that the loss may be mistaken for a late or heavy period.1PubMed Central. Confined placental mosaicism of trisomy 6 detected through genome‐wide NIPT was associated with placental abruption Studies of products of conception from first-trimester losses have identified trisomy 6 among chromosomal abnormalities, but it is far less commonly reported than trisomies of chromosomes 16, 21, or 22, partly because so many affected embryos are lost before a clinical pregnancy is even recognized.
The lethality comes down to the sheer volume of genetic material involved. Humans tolerate extra copies of some smaller chromosomes (trisomy 21, for instance, is survivable because chromosome 21 is the smallest autosome with relatively few genes). Chromosome 6 is mid-sized and gene-dense, so the metabolic disruption from an extra copy is too great for an embryo to compensate. No confirmed case of a liveborn infant with full (non-mosaic) trisomy 6 has been reported in the medical literature.
Mosaic Trisomy 6 in Liveborns
Mosaicism occurs when a chromosomal error happens after fertilization, during one of the early cell divisions of the embryo. The result is a body made up of two cell lines: some cells with the normal two copies of chromosome 6, and others with three. If the trisomic cells make up a small enough fraction, the embryo can sometimes develop well enough to survive to birth.
This is vanishingly rare. The first documented liveborn infant with trisomy 6 mosaicism was reported in 2001.2PubMed. Patient with trisomy 6 mosaicism Since then, the literature has remained sparse, with only a handful of additional cases described. The clinical features vary depending on what percentage of cells carry the extra chromosome and which tissues are affected. Because so few cases exist, there is no well-defined syndrome with a predictable set of features the way there is for conditions like Down syndrome. Reported problems have included developmental delays, growth restriction, and various congenital anomalies, but with so small a case count, it is difficult to say which features are consistently linked to the extra chromosome 6 and which are coincidental.
A more recent case report described a pregnancy in which amniocentesis showed mosaic trisomy 6 in amniotic fluid cells. After birth, standard chromosome testing on the infant’s blood showed a normal result, while closer analysis of placental tissue revealed trisomy 6 signals in a small fraction of cells.3Taiwanese Journal of Obstetrics and Gynecology. Clinical course and genetic analysis of a case of the amniocentesis showing chromosome 6 trisomy mosaicism This illustrates a recurring theme with trisomy 6: the abnormality is often confined to specific tissues and may not show up at all in a routine blood draw after birth.
How Trisomy 6 Gets Detected
Most cases of trisomy 6 come to light through one of three routes: prenatal cell-free DNA screening, invasive diagnostic testing during pregnancy, or genetic analysis of miscarriage tissue.
Cell-free DNA screening (often called NIPT) analyzes fragments of placental DNA circulating in the pregnant person’s blood. Because it reads placental DNA rather than fetal DNA, a positive signal for trisomy 6 does not necessarily mean the fetus is affected. It could reflect confined placental mosaicism, where the placenta carries the trisomy but the fetus does not. For this reason, a positive NIPT result for trisomy 6 always requires follow-up with an invasive test.
Current guidance for pregnancies flagged by cell-free DNA screening for a trisomy involving an imprinted chromosome, including chromosome 6, recommends chorionic villus sampling (CVS) as a first step, followed by amniocentesis if CVS is abnormal. If the fetus turns out to be unaffected, additional testing for uniparental disomy should still be considered, since even a chromosomally normal fetus can carry UPD as a consequence of how the trisomy was corrected.4Wiley Online Library. Diagnostic testing after positive results on cell free DNA screening: CVS or Amnio? This two-step approach matters because CVS samples the placenta while amniocentesis samples fluid from around the fetus, and comparing results from both can reveal whether the trisomy is confined to the placenta or present in the fetus as well.
In pregnancies that end in miscarriage, chromosomal analysis of the tissue can identify trisomy 6 as the cause. This information is sometimes valuable for counseling about recurrence risk in future pregnancies, though isolated trisomies like this are generally considered sporadic events rather than inherited conditions.
Confined Placental Mosaicism
Confined placental mosaicism (CPM) is the situation in which a chromosomal abnormality exists in the placenta but not in the fetus. For trisomy 6, this is the most commonly encountered scenario in ongoing pregnancies. It arises because the placenta and the fetus develop from different cell lineages very early in embryonic development. If the error that created the trisomy happened in a cell destined to become placental tissue, the placenta carries the abnormality while the fetus escapes it.
CPM involving trisomy 6 is not always benign, however. Even when the fetus itself is chromosomally normal, a trisomic placenta may not function as well as a normal one. One documented case linked confined placental mosaicism of trisomy 6, detected through genome-wide NIPT, with placental abruption, a dangerous complication in which the placenta separates from the uterine wall before delivery.1PubMed Central. Confined placental mosaicism of trisomy 6 detected through genome‐wide NIPT was associated with placental abruption This means that even reassuring fetal test results after a positive NIPT for trisomy 6 warrant continued monitoring of the pregnancy for complications related to placental function.
The challenge for clinicians is that CPM is not easily detectable without invasive testing, and the clinical significance varies from case to case. Some pregnancies with CPM for trisomy 6 proceed normally; others experience growth restriction or placental complications. There is no reliable way to predict at the time of diagnosis which outcome is more likely, which is why closer surveillance is generally recommended.
Trisomy Rescue and Uniparental Disomy
One of the more counterintuitive consequences of trisomy 6 involves what happens when the embryo partially “corrects” the error on its own. In a process called trisomy rescue, a cell that starts with three copies of a chromosome loses one of them during division, returning to the normal count of two. If this corrected cell line goes on to populate the fetus while the trisomic cells remain confined to the placenta, the fetus can develop normally. The problem arises in which copy gets discarded.
Each person normally inherits one copy of every chromosome from their mother and one from their father. If trisomy rescue happens and the cell randomly discards the sole copy from one parent, the fetus ends up with two copies from the other parent and zero from the first. This is uniparental disomy, or UPD. The formation of UPD through trisomy rescue has been well described as a mechanism for several chromosomes.5PubMed. Origin of uniparental disomy 6: presentation of a new case and review on the literature
For chromosome 6, UPD matters because certain genes on this chromosome are imprinted, meaning they are only active when inherited from a specific parent. When both copies come from one parent, some genes that should be silenced are active, or genes that should be active are silent. The consequences depend on whether the two copies are maternal or paternal in origin.
The first reported prenatal diagnosis of trisomy 6 rescue resulting in paternal UPD6 described clinical, genetic, and placental findings in a female infant.6PubMed. Prenatal diagnosis of trisomy 6 rescue resulting in paternal UPD6 with novel placental findings This is why the diagnostic recommendations mentioned earlier emphasize testing for UPD even after fetal chromosomes appear normal. The chromosomes may all be present in the right number, but if both copies of chromosome 6 came from the same parent, the imprinting effects can still cause problems.
What Paternal UPD6 Does
When both copies of chromosome 6 come from the father, the most recognized consequence is transient neonatal diabetes mellitus (TNDM). This is a rare form of diabetes that appears shortly after birth, typically resolves within the first six months of life, but can predispose the individual to type 2 diabetes later in adulthood. Research has localized the responsible imprinted gene to a region on the long arm of chromosome 6, around 6q22 to 6q23, and established that it is paternally expressed.7Oxford Academic. Further Evidence for an Imprinted Gene for Neonatal Diabetes Localised to Chromosome 6q22–q23
The connection between paternal UPD6 and neonatal diabetes has been documented across multiple patients. Transient neonatal diabetes has been associated with several types of abnormalities involving the paternally inherited copy of chromosome 6, including duplications of part of the long arm and uniparental disomy. In all reported cases of TNDM with UPD, the patients had complete paternal isodisomy, meaning both chromosome 6 copies were identical and came from the father.8PubMed Central. Partial paternal uniparental disomy of chromosome 6 in an infant with neonatal diabetes, macroglossia, and craniofacial abnormalities Beyond diabetes, some of these infants also had macroglossia (an enlarged tongue) and craniofacial abnormalities, suggesting that the overexpression of paternally active imprinted genes on chromosome 6 has effects beyond glucose regulation.
The “transient” label is somewhat misleading, because while the neonatal diabetes resolves, the metabolic vulnerability does not fully disappear. A meaningful proportion of individuals who had TNDM go on to develop diabetes again in adolescence or adulthood, presumably because the same imprinting abnormality continues to affect insulin-regulating pathways even after the acute neonatal phase passes.
What Maternal UPD6 Does
When both copies of chromosome 6 come from the mother instead, the picture is different. The most consistently reported feature of maternal UPD6 is intrauterine growth restriction (IUGR), meaning the fetus grows more slowly than expected during pregnancy. A literature review identified a total of 19 reported cases of maternal UPD6, and IUGR along with preterm labor were the two most common findings.9PubMed Central. Maternal uniparental disomy for chromosome 6 in 2 prenatal cases with IUGR: case report and literature review Some cases also had additional anomalies or genetic variations, but the association with growth restriction has been the most reproducible observation.10PubMed Central. Clinical features associated with maternal uniparental disomy for chromosome 6
The growth restriction seen in maternal UPD6 likely reflects the opposite side of the same imprinting coin. If paternal expression of certain chromosome 6 genes promotes growth (and its overactivity in paternal UPD causes oversized features like macroglossia), then the absence of paternal copies in maternal UPD would leave those growth-promoting genes silent, resulting in a smaller baby. This kind of parent-of-origin tug-of-war over fetal growth is a recurring theme in imprinting biology and has been well described for other chromosomes too.
Partial Trisomy 6 and Ring Chromosome 6
Not all chromosome 6 abnormalities involve a complete extra copy. Partial trisomy 6 occurs when only a segment of the chromosome is duplicated. The most studied version is partial trisomy 6p, involving extra material from the short arm of chromosome 6. This is characterized by low birth weight, developmental delay, craniofacial abnormalities, feeding difficulties, congenital heart defects, and kidney abnormalities. Pure partial trisomy 6p, where the extra material comes solely from chromosome 6 without involvement of other chromosomes, is especially rare and can arise from several structural rearrangements including marker chromosomes, tandem duplications, or interchromosomal insertions.11PubMed Central. De novo Pure Partial Trisomy 6p Associated with Facial Dysmorphism, Developmental Delay, Brain Anomalies, and Primary Congenital Hypothyroidism
Ring chromosome 6 is another structural variant worth knowing about. It forms when both ends of chromosome 6 break off and the remaining piece fuses into a ring shape, effectively losing genetic material from both tips. The clinical consequences vary widely. A review of ring chromosome 6 cases in fetuses found that the spectrum ranges from incidental detection during routine testing (in one case, amniocentesis done solely because of maternal age) to severe outcomes including hydrocephalus and multiple congenital anomalies. The only consistent finding across postnatal cases was growth retardation.12Wiley Online Library. Ring chromosome 6 in three fetuses: case reports, literature review, and implications for prenatal diagnosis
The variability in ring chromosome 6 makes prenatal counseling particularly difficult. Two fetuses with what looks like the same chromosomal finding on a karyotype can have dramatically different outcomes depending on exactly how much genetic material was lost when the ring formed and how stable the ring is during subsequent cell divisions. Ring chromosomes are inherently unstable; they tend to be lost or duplicated during cell division, which creates its own form of mosaicism over time.
What Causes the Error in the First Place
The underlying event behind most trisomies, including trisomy 6, is nondisjunction, the failure of a pair of chromosomes to separate properly during the formation of eggs or sperm. When an egg or sperm carrying two copies of a chromosome (instead of one) joins with a normal partner at fertilization, the resulting embryo has three copies.
Advanced maternal age is the best-established risk factor for nondisjunction events generally. Research on trisomy 21 (Down syndrome) has shown that the association between maternal age and trisomy is driven specifically by errors during egg cell development, not sperm production or post-fertilization cell division.13PubMed Central. Maternal age and risk for trisomy 21 assessed by the origin of chromosome nondisjunction: a report from the Atlanta and National Down Syndrome Projects Whether the same maternal-age relationship holds specifically for trisomy 6 is harder to establish because the condition is so uniformly lethal that there are far fewer cases to study. The general consensus is that the same biological aging process that makes eggs more prone to chromosome 21 errors also increases the risk for other trisomies, but the precise risk curves vary by chromosome.
For mosaic trisomy 6, the error sometimes happens after fertilization rather than during egg or sperm formation. A normal embryo starts dividing, and during one of those early divisions a daughter cell ends up with an extra chromosome 6. Because this is a post-fertilization event, it is not clearly linked to parental age in the same way as meiotic nondisjunction. The randomness of this type of error is part of why mosaic trisomy 6 is so unpredictable in its severity: the timing of the division error determines what fraction of the body’s cells are affected and which tissues those cells end up in.
Prognosis Across the Spectrum
Prognosis for anything involving an extra chromosome 6 depends entirely on the specific type and degree of abnormality.
- Complete trisomy 6: Incompatible with life. Nearly all affected pregnancies end in first-trimester miscarriage.
- Mosaic trisomy 6 in the fetus: Extremely rare in liveborns. Outcomes range widely based on the percentage of trisomic cells and the tissues involved. Too few cases exist to give reliable predictions, and each case is essentially unique.
- Confined placental mosaicism: The fetus itself may be chromosomally normal, and many of these pregnancies have good outcomes. However, the abnormal placenta can cause complications including growth restriction and abruption, so increased monitoring is warranted.
- Paternal UPD6: Associated with transient neonatal diabetes, which usually resolves in infancy but carries a risk of diabetes recurrence later in life.
- Maternal UPD6: Associated with growth restriction during pregnancy and sometimes preterm birth, but postnatal outcomes are less well characterized given the small number of reported cases.
- Partial trisomy 6p: Developmental delay and multiple congenital anomalies are common, though severity varies with the size and specific location of the duplicated segment.
For families receiving a prenatal diagnosis involving chromosome 6, the most important step is detailed follow-up testing to determine exactly what type of abnormality is present. A positive NIPT result, for example, could represent anything from confined placental mosaicism with a normal fetus to true fetal mosaicism, and the management and prognosis are different for each. Genetic counseling is particularly important here because the rarity of trisomy 6 means many obstetricians will not have encountered it before, and the nuances of imprinting and UPD add layers of complexity that require specialist input.
Why Chromosome 6 Is Imprinting Territory
Chromosome 6 belongs to a select group of human chromosomes where imprinting plays a clinically meaningful role. Imprinted genes are those whose activity depends on which parent they came from. Most genes are active from both the maternal and paternal copies, but imprinted genes break this rule: one copy is chemically silenced based on its parent of origin, leaving only the other parent’s copy active.
The practical consequence is that for imprinted regions, the usual genetic math does not apply. Having two normal copies of chromosome 6 is not sufficient if both came from the same parent, because the imprinting marks are wrong. A gene that should be active (because it is supposed to come from dad) sits silent on both copies (because both carry mom’s silencing marks), or vice versa. This is why UPD for chromosome 6 causes problems even though the total number of chromosomes is normal and no genes are missing or duplicated.
The chromosomes where imprinting matters most in human health include chromosomes 6, 7, 11, 14, 15, and 20. Each has its own set of imprinted genes and its own characteristic problems when UPD occurs. The best-known examples are on chromosome 15, where maternal UPD causes Angelman syndrome and paternal UPD causes Prader-Willi syndrome. Chromosome 6’s imprinting effects are less widely recognized outside genetics, partly because the conditions they cause (neonatal diabetes and growth restriction) are less distinctive and harder to connect to a chromosomal cause without specialized testing. But the principle is the same: parent of origin matters as much as gene content for this part of the genome.